文献速递造血干细胞移植与细胞治疗

AhR激活通过减少小胶质细胞NF-κB信号减轻中枢神经系统移植物抗宿主病

AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling.
PubMed 文献 · Blood Adv · 2025-01-01

研究探讨抗生素改变微生物组对中枢神经系统移植物抗宿主病(CNS GVHD)的影响及干预策略。小鼠同种异体造血细胞移植后抗生素治疗增加脑内小胶质细胞数量并促炎极化,伴AhR配体吲哚-3-乙酸减少;AhR配体FICZ可逆转上述改变并抑制NF-κB活性。CNS GVHD患者中枢神经系统中吲哚-3-乙酸亦减少且小胶质细胞NF-κB表达增加。

要点

  • 抗生素治疗使移植小鼠脑内小胶质细胞增多并呈高度分支形态,NF-κB与Src活性增加。
  • 抗生素导致脑内细菌来源AhR配体吲哚-3-乙酸耗竭,FICZ处理可逆转小胶质细胞扩增与形态改变并降低NF-κB活性。
  • CNS GVHD患者中枢神经系统中吲哚-3-乙酸减少且小胶质细胞NF-κB表达增加。

核心结论

  • 抗生素治疗及随后AhR配体减少导致CNS GVHD中小胶质细胞活化增加。
  • FICZ通过抑制NF-κB活性减轻中枢神经炎症,为干预致病性小胶质细胞信号及CNS GVHD提供代谢调节剂。

研究设计与样本

  • 研究采用小鼠同种异体造血细胞移植模型及原代小胶质细胞实验,并检测CNS GVHD患者中枢神经系统样本。

主要发现

  • 抗生素治疗的小鼠脑内小胶质细胞数量增加,形态向高度分支表型转变,NF-κB与Src活性增加。
  • 抗生素治疗导致脑内细菌来源AhR配体吲哚-3-乙酸耗竭。
  • AhR配体FICZ处理原代小胶质细胞降低NF-κB活性与吞噬潜能。
  • FICZ处理逆转小胶质细胞扩增与形态改变。
  • 发生急性GVHD的患者中枢神经系统中吲哚-3-乙酸减少且小胶质细胞NF-κB表达增加。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute graft-versus-host disease (GVHD) that occurs after allogeneic hematopoietic cell transplantation (allo-HCT) can affect the central nervous system (CNS). Most patients who have undergone allo-HCT receive antibiotic treatment, which alters the microbiome and essential microbiome-derived metabolites. We investigated the impact of microbiome modifications on CNS GVHD and therapeutic strategies to overcome the microbiome-derived metabolite depletion. Antibiotic treatment of mice undergoing allo-HCT increased microglia numbers in the brain, indicating increased inflammation. In addition, microglial morphology shifted toward a highly branched phenotype. Consistent with a proinflammatory phenotype, the microglia exhibited increased NF-κB and Src activity. Antibiotic treatment caused the depletion of the bacteria-derived aryl hydrocarbon receptor (AhR) ligand indole-3-acetate in the brain. Conversely, treatment of the primary microglia with the AhR ligand 6-formylindolo(3,2-b)carbazole (FICZ) reduced NF-κB activity and phagocytic potential. Microglia expansion and morphological changes were reversed by AhR ligand FICZ treatment. Moreover, the AhR ligand indole-3-acetate was also reduced in the CNS of patients who developed acute GVHD concomitant with increased microglial NF-κB expression. In summary, we demonstrated that antibiotic treatment and a subsequent decrease of AhR ligands resulted in increased microglial activation in CNS GVHD. FICZ treatment hampered CNS inflammation by inhibiting NF-κB activity, thereby providing a metabolic modifier to interfere with pathogenic microglia signaling and CNS GVHD in vivo.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Zähringer A, Morgado I, Erny D, et al. AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling. Blood Adv. 2025. PMID: 40163754. doi:10.1182/bloodadvances.2024015000

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。